NCT01924169: Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) |
|
|
| Terminated | 2 | 3 | US | Lenalidomide, CC-5013, Revlimid, Influenza Vaccine, TIV, Pneumovax Vaccine, Pneumonia vaccine | M.D. Anderson Cancer Center, Celgene Corporation | Hematologic Disorder | 02/17 | 02/17 | | |
